Summary
Arotinoids are a new class of retinoids with particular biological properties. Arotinoid Ro 13-6298 in minute quantities leads to regression of chemically induced papillomas of the skin of mice. The ratio between the antipapilloma effect and the toxic syndrome of hypervitaminosis A is very favorable. Ro 13-6298 also has a therapeutic influence on chemically induced skin carcinomas in mice. As the papilloma model has proved to be suitable for screening for antipsoriatic and antikeratinizing properties as well as for antineoplastic screening, arotinoids might be useful in human clinical dermatology and oncology.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bollag W (1974) Therapeutic effects of an aromatic retinoic acid analog on chemically induced skin papillomas and carcinomas of mice. Eur J Cancer 10: 731–737
Bollag W (1975) Prophylaxis of chemically induced epithelial tumors with an aromatic retinoic acid analog (Ro 10-9359). Eur J Cancer 11: 721–724
Bollag W, Matter A (1981) From vitamin A to retinoids in experimental and clinical oncology: achievements, failures and outlook. Ann NY Acad Sci 359: 9–23
Loeliger P, Bollag W, Mayer H (1980) Arotinoids, a new class of highly active retinoids. Eur J Med Chem 15: 9–15
Orfanos CE, Braun-Falco O, Farber EM, Grupper C, Polano M, Schuppli R (1981) Retinoids. Proceedings of the International Dermatology Symposium: Advances in Basic Research and Therapy. Springer, Berlin Heidelberg New York
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bollag, W. Arotinoids. Cancer Chemother. Pharmacol. 7, 27–29 (1981). https://doi.org/10.1007/BF00258209
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00258209